by TractManager | Jan 30, 2023 | Emerging Technology Report
Humacyl is an off-the-shelf bioengineered human acellular vessel proposed for use in the repair of vascular trauma. This technology uses a process to decellularize donated human vascular smooth muscle cells, while preserving extracellular matrix proteins. This results...
by TractManager | Jan 30, 2023 | Emerging Technology Report
The WiSE CRT system is a wireless left ventricular pacing system that works with an implanted right ventricular pacemaker and/or defibrillator for patients in whom cardiac resynchronization therapy (CRT) is indicated. If you have a Hayes login, click here to view the...
by TractManager | Jan 26, 2023 | Evolving Evidence Review
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of cooled radiofrequency ablation (CRFA) using the Coolief system (Avanos Medical Inc.) for relief of pain and...
by TractManager | Jan 26, 2023 | Health Technology Assessment
Focus of the Report: The focus of this Health Technology Assessment is to evaluate the effectiveness and safety of the minimally invasive lumbar decompression (mild) procedure, an approach that uses a proprietary surgical kit (mild; Vertos Medical Inc.) to treat...
by TractManager | Jan 26, 2023 | Emerging Technology Report
Tofersen is an investigational antisense oligonucleotide proposed for the treatment of amyotrophic lateral sclerosis (ALS) caused by mutations in the SOD1 gene.If you have a Hayes login, click here to view the full report on the Knowledge Center.
Recent Comments